You have 9 free searches left this month | for more free features.

sunitinib

Showing 26 - 50 of 196

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastrointestinal Stromal Tumors Trial in Tokyo (Pimitespib, Imatinib, Sunitinib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Tokyo, Japan
    A site selected by Taiho Pharmaceutical Co., Ltd.
Aug 4, 2022

Small Cell Lung Cancer Trial in United States (irinotecan, Carboplatin, sunitinib)

Completed
  • Small Cell Lung Cancer
  • Fort Myers, Florida
  • +9 more
Nov 19, 2021

Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,

Completed
  • Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab
  • +3 more
  • Duarte, California
  • +13 more
Nov 30, 2021

Type B3 Thymoma, Thymic Carcinoma Trial in Milan (Sunitinib)

Recruiting
  • Type B3 Thymoma
  • Thymic Carcinoma
  • Sunitinib
  • Milan, Italy
    National Cancer Institute
Jun 8, 2021

Carcinoma, Renal Cell Trial in China, Korea, Republic of, Taiwan (Pazopanib, Sunitinib)

Completed
  • Carcinoma, Renal Cell
  • Guangzhou, Guangdong, China
  • +20 more
Dec 6, 2021

Kidney Cancer Trial in Boston, Houston, Salt Lake City (Everolimus, Sunitinib)

Terminated
  • Kidney Cancer
  • Boston, Massachusetts
  • +3 more
Apr 26, 2021

Glioblastoma Multiforme, Glioblastoma, Adult, Glioblastoma Trial in Amsterdam, Groningen, Nijmegen (Sunitinib, Lomustine)

Recruiting
  • Glioblastoma Multiforme
  • +4 more
  • Amsterdam, Netherlands
  • +2 more
Apr 14, 2021

Advanced Rare Tumours Trial in Canada (Sunitinib, Temsirolimus)

Active, not recruiting
  • Advanced Rare Tumours
  • Calgary, Alberta, Canada
  • +16 more
Mar 17, 2022

Metastatic Renal Cell Carcinoma Who Received Sunitinib After 1st

Completed
  • Metastatic Renal Cell Carcinoma (mRCC)
  • sunitinib
  • Calgary, Alberta, Canada
    University of Calgary
Mar 8, 2021

Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)

Active, not recruiting
  • Carcinoma
  • +7 more
  • La Jolla, California
  • +58 more
Jan 13, 2023

Sunitinib In Chinese Progressive Advanced Or Metastatic

Active, not recruiting
  • Pancreatic Neuroendocrine Tumors
  • sunitinib
  • Hefei, Anhui, China
  • +15 more
Oct 19, 2021

NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Carcinoma, Renal Cell Trial in Durham (Sunitinib)

Completed
  • Carcinoma, Renal Cell
  • Sunitinib
  • Durham, North Carolina
    Duke Cancer Institute
Nov 23, 2020

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

Completed
  • Renal Cell Cancer Metastatic
  • +2 more
  • Sunitinib
  • Berlin, Germany
    Experimental and Clinical Research Center, Clinical Research Uni
Jan 25, 2021

Carcinoma, Renal Cell Trial in Worldwide (BIBF 1120, sunitinib)

Completed
  • Carcinoma, Renal Cell
  • BIBF 1120
  • sunitinib
  • Pecs, Hungary
  • +14 more
Jun 16, 2021

Renal Cell Carcinoma Who Received First-Line Sunitinib

Completed
  • Metastatic Renal Cell Carcinoma
  • Sunitinib
  • Calgary, Alberta, Canada
    University of Calgary
Feb 19, 2021

Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1 Trial in

Recruiting
  • Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1
  • Biological : Toripalimab Drug: Axitinib
  • sunitinib
  • Beijing, China
    Beijing Cancer Hospital
Jan 24, 2021

Metastatic Renal Cell Cancer Trial in France (Pazopanib, Sunitinib)

Completed
  • Metastatic Renal Cell Cancer
  • Bordeaux, France
  • +7 more
Jan 11, 2021

Gastrointestinal Stromal Tumors Trial in United States (PLX9486, Pexidartinib, Sunitinib)

Completed
  • Gastrointestinal Stromal Tumors
  • Miami, Florida
  • +5 more
Apr 30, 2021

Patterns With Targeted Therapies In Mrcc In Sweden - A

Completed
  • Kidney Neoplasms
  • Sollentuna, Sweden
    Pfizer Innovations AB
Sep 8, 2021

Cancer Trial in Canada, United States (BBI503, Capecitabine, Doxorubicin)

Completed
  • Cancer
  • Fort Wayne, Indiana
  • +7 more
Apr 4, 2022

Metastatic Renal Cell Carcinoma Trial in Wien, Essen (Nivolumab, Sunitinib, Pazopanib)

Terminated
  • Metastatic Renal Cell Carcinoma
  • Wien, Austria
  • +1 more
Sep 7, 2021

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
Jan 9, 2023

Clear Cell Renal Carcinoma Trial in Spain (Sunitinib)

Completed
  • Clear Cell Renal Carcinoma
  • Sunitinib
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +8 more
Nov 12, 2020

Gastrointestinal Stromal Tumors Trial in Worldwide (Masitinib, Sunitinib)

Completed
  • Gastrointestinal Stromal Tumors
  • Saint Louis, Missouri
  • +4 more
Dec 7, 2020